slow responders to glp 1 Understanding GLP-1 in Weight Loss GLP-1 Non Responders: Why Therapy

R.et al (2026)

GLP-1 agonist medications can change how some medicines work, and other medicines may affect how GLP-1 medications work too

Davies said weight loss of up to 5% can improve hyperglycemia and hypertension, 5% to 10% weight loss can prevent type 2 diabetes and improve polycystic ovary syndrome and dyslipidemia, 10% to 15% weight loss can lead to improvements in cardiovascular disease and 15% or greater weight loss may induce type 2 diabetes remission and lower risks for CV mortality and heart failure with preserved ejection fraction

The entire data mining, data normalisation, and pathway activity predictions were automated in our in-house R software package as described in Smart et al